Our expert scientists. Your custom assay.
Understanding the effects of your test biologic or small molecule on cells in the CNS is likely a key component of your drug discovery program.
At Aquila, we offer a suite of primary neuronal and glial cell-based assays to help you understand the interaction between your compound or biologic and the nervous system, taking you to clinic faster.
We have routine access to rodent brains and our highly experienced team can isolate primary CNS cells expressing endogenous targets of interest for use in moderate-throughput phenotypic screening of multiple compounds and MOA studies, helping you achieve accurate, robust results.
Please contact us today to learn more about our primary CNS cell-based assays.